Professor at @UCT_News; Neville Isdell Chair; Founder and Director of H3D research centre; Editor-In-Chief at ACS Medicinal Chemistry Letters.

Cape Town, South Africa
Joined August 2020
Our editors are catalysts for scientific progress as active researchers at top institutions. With expertise and global reach, they champion original research that shapes the future. Join a community committed to advancing science and submit today: go.acs.org/ezq
1
1
2
607
In the July Issue of #ACSMedChemLett Elena De Vita describes three must read articles. go.acs.org/eqN
1
2
395
The June Issue of #ACSMedChemLett is out today! Sara Goldstein describes three must read articles this month In this Issue: go.acs.org/ejs
1
219
📢 Call for Abstracts: ACS150 JACS Symposium Series: University of Cape Town - Molecules to Medicine: Advancing Health Innovation in Africa! 📍 @UCT_news 📅 10-11 September Submit your abstract before 10 June 2026.  🔗 Apply today:  go.acs.org/eh5
1
2
251
Kelly Chibale retweeted
Announcing Call for Papers for Special Issue on Allosteric Modulators in Drug Discovery. pubs.acs.org/doi/10.1021/acs…
1
99
Don't forget to register for our upcoming webinar, where winners of the 2026 Portoghese Lectureship Award will be discussing 'Emerging Medicinal Chemistry Approaches to Targeting Disease Pathways’. 📅 June 3, 12:00PM EDT Register to attend: go.acs.org/eg0
1
1
305
📢 Call for Abstracts: ACS150 JACS Symposium Series: University of Cape Town - Molecules to Medicine: Advancing Health Innovation in Africa! 📍 @UCT_news 📅 10-11 September Submit your abstract before 10 June 2026.  🔗 Apply today:  go.acs.org/efU
1
2
315
Congratulations Kelly Chibale of @UCT_news, newly inducted NAS international member! #NAS163 #NASmember #chemistry #biology #pharmacology
8
31
1,720
Congratulations to Schmidt Sciences' AI2050 Senior Fellow @Kelly_Chibale on being named an Honorary Fellow of the @RoySocChem. Dr. Chibale was one of seven world-renowned scientists recognized with the RSC's top accolade this year. rsc.org/news/2026-honorary-f…
3
7
518
The December issue of #ACSMedChemLett is out today! Amanda Dombrowski summarizes three must read articles In this Issue. go.acs.org/dyI
2
11
563
For the 1-year anniversary of our International Research Network, we're featuring ongoing research from Dr. @Kelly_Chibale & @dr_vinayaksingh Working with Dr. @CCapicciotti, this project is examining nanocluster-bacterial interactions' potential against antimicrobial resistance.
1
3
169
Explore recent developments in CDK-targeting PROTACs-covering linker chemistry, SAR insights, and emerging degradation strategies in cancer therapy. #PROTAC #ACSMedChemLett @ACSPublications @mark_blaskovich @IMBatUQ go.acs.org/dtB
2
4
586
just scored this book in the second hand bookstore across the road, ahead of the 6th H3D meeting on drug discovery and global health organized in 2026 by @Kelly_Chibale
1
3
222
Meet PKM2Pred (go.acs.org/dqF), where AI meets oncology! Instantly discover and predict potent PKM2 modulators, driving faster and smarter anticancer drug discovery. #ACSMedChemLett go.acs.org/dqE
1
382
Kelly Chibale retweeted
The wait is over – the #WCP2026 preliminary program is now LIVE! 🎉 Get ready to explore world-class #pharmacology research and innovation coming to #Melbourne #Australia in July 2026. 👉wcp2026.org/ #ASCEPT #IUPHAR #VISITMELBOURNE
3
3
360
Congratulations to AI2050 Senior Fellow Dr. @Kelly_Chibale for being honored as a Distinguished International Fellow by the @ASTMH, recognizing his contributions to tropical medicine, chemistry, drug discovery, and global health.
3
1
20
1,758
In London today, to meet alumni and supporters - including Nobel Prize Winner @demishassabis of @GoogleDeepMind. So grateful for their ongoing support and cheerleading for @QueensCam and for @Cambridge_Uni, market leaders for innovation and excellence.
5
4
22
2,660
Kelly Chibale retweeted
In advance of our Annual Meeting in Toronto, Nov 9-13, this Q&A with ASTMH President David Fidock discussing malaria appeared in the Toronto Star on Monday. tinyurl.com/49h4x4fk
12
30
1,525
This article from Accent Tx details the discovery of ATX020, a potent KIF18A inhibitor with favorable kinesin selectivity, ADME properties, and efficacy in the OVCAR-3 cell-derived xenograft model. #ACSMedChemLett go.acs.org/dl2
2
1
12
1,136
Prof. @Kelly_Chibale @UCT_News delivered a fascinating talk on "Chemical biology and modelling in repurposing human kinase inhibitors for malaria" @GSC_2025 @ACSBioMed @iitbombay @ruchianand1975 @anidchemiitb
2
5
286